Lee Flowers's most recent trade in HCW Biologics Inc was a trade of 962 Common Stock done at an average price of $26 . Disclosure was reported to the exchange on May 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 26.00 per share. | 07 May 2025 | 962 | 5,720 | - | 26 | 25,012 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 07 May 2025 | 481 | 481 | - | - | Common Stock Purchase Warrant | |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Grant, award, or other acquisition of securities at price $ 1.40 per share. | 20 Feb 2024 | 71,429 | 190,238 | - | 1.4 | 100,001 | Common Stock |
| HCW Biologics Inc | Flowers Lee | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Dec 2023 | 7,501 | 0 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Flowers Lee | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 08 Dec 2023 | 7,501 | 118,809 | - | 0.1 | 1,050 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2021 | 4,285 | 12,857 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.14 per share. | 01 Dec 2021 | 4,285 | 95,952 | - | 0.1 | 600 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Sep 2021 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 4.08 per share. | 20 Aug 2021 | 7,853 | 86,062 | - | 4.1 | 32,069 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 3.95 per share. | 20 Aug 2021 | 5,605 | 91,667 | - | 4.0 | 22,157 | Common Stock |
| HCW Biologics Inc | Lee Flowers | SVP of Business Development | Purchase of securities on an exchange or from another person at price $ 4.29 per share. | 19 Aug 2021 | 10,532 | 78,209 | - | 4.3 | 45,218 | Common Stock |